Nonsteroidal anti-inflammatory drug treatment for postoperative pericardial effusion: A multicenter randomized, double-blind trial

Annals of Internal Medicine

Volumn 152, Issue 3, 2010, Pages 137-143

  Meurin, Philippe ^a   Tabet, Jean Yves ^a   Thabut, Gabriel ^b   Cristofini, Pascal ^c   Farrokhi, Titi ^d   Fischbach, Michel ^e   Pierre, Bernard ^f   Ben Driss, Ahmed ^a   Renaud, Nathalie ^a   Iliou, Marie Christine ^c   Weber, Hélène ^a  

^a Les Grands Pres   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL BROUSSAIS   (France)

^d Hopital de Bligny   (France)

^e Château Lemoine   (France)

^f Centre IRIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; ESOMEPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART SURGERY; HEART TAMPONADE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERICARDIAL EFFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REHABILITATION CENTER; SIDE EFFECT; SKIN ALLERGY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIAC SURGICAL PROCEDURES; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; PROSPECTIVE STUDIES;

EID: 75749115183     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-3-201002020-00004     Document Type: Article

References (19)

1. Weitzman LB, Tinker WP, Kronzon I, Cohen ML, Glassman E, Spencer FC. The incidence and natural history of pericardial effusion after cardiac surgery-an echocardiographic study. Circulation. 1984;69:506-11. [PMID: 6692512]
2. Pepi M, Muratori M, Barbier P, Doria E, Arena V, Berti M, et al. Pericardial effusion after cardiac surgery: incidence, site, size, and haemodynamic conse-quences. Br Heart J. 1994;72:327-31. [PMID: 7833189]
3. Tsang TS, Barnes ME, Hayes SN, Freeman WK, Dearani JA, Butler SL, et al. Clinical and echocardiographic characteristics of significant pericardial effusions following cardiothoracic surgery and outcomes of echo-guided pericardiocentesis for management: Mayo Clinic experience, 1979-1998. Chest. 1999;116: 322-31. [PMID: 10453858]
4. Kuvin JT, Harati NA, Pandian NG, Bojar RM, Khabbaz KR. Postoperative cardiac tamponade in the modern surgical era. Ann Thorac Surg. 2002;74:1148-53. [PMID: 12400760]
5. Meurin P, Weber H, Renaud N, Larrazet F, Tabet JY, Demolis P, et al. Evolution of the postoperative pericardial effusion after day 15: the problem of the late tamponade. Chest. 2004;125:2182-7. [PMID: 15189940]
6. Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y; Task Force on the Diagnosis and Management of Pricardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Eur Heart J. 2004;25:587-610. [PMID: 15120056]
7. Little WC, Freeman GL. Pericardial disease. Circulation. 2006;113:1622-32. [PMID: 16567581]
8. Hoit BD. Management of effusive and constrictive pericardial heart disease. Circulation. 2002;105:2939-42. [PMID: 12081983]
9. Gislason GH, Jacobsen S, Rasmussen JN, Rasmussen S, Buch P, Friberg J, et al. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation. 2006;113:2906-13. [PMID: 16785336]
10. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA; American Heart Association. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115:1634-42. [PMID: 17325246]
11. Huerta C, Castellsague J, Varas-Lorenzo C, Garc?́a Rodr?́guez LA. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45:531-9. [PMID: 15754275]
12. Loboz KK, Shenfield GM. Drug combinations and impaired renal function-the 'triple whammy'. Br J Clin Pharmacol. 2005;59:239-43. [PMID: 15676048]
13. Hernández-Díaz S, Rodríguez LA. Association between nonsteroidal antiinflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med. 2000;160:2093-9. [PMID: 10904451]
14. Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5:19-34. [PMID: 17456832]
15. Imazio M, Cecchi E, Trinchero R; COPPS Investigators. Colchicine for the prevention of the postpericardiotomy syndrome: the COPPS trial [Letter]. Int J Cardiol. 2007;121:198-9. [PMID: 17134774]
16. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352:1081-91. [PMID: 15713945]
17. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001;345:1809-17. [PMID: 11752357]
18. Béland MJ, Paquet M, Gibbons JE, Tchervenkov CI, Dobell AR. Pericardial effusion after cardiac surgery in children and effects of aspirin for prevention. Am J Cardiol. 1990;65:1238-41. [PMID: 2337034]
19. Niva M, Biancari F, Valkama J, Juvonen J, Satta J, Juvonen T. Effects of diclofenac in the prevention of pericardial effusion after coronary artery bypass surgery. A prospective, randomized study. J Cardiovasc Surg (Torino). 2002;43: 449-53. [PMID: 12124550]